Literature DB >> 12456880

Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Felicia D Goodrum1, Craig T Jordan, Kevin High, Thomas Shenk.   

Abstract

Human cytomegalovirus (HCMV) resides latently in hematopoietic cells of the bone marrow. Although viral genomes can be found in CD14+ monocytes and CD34+ progenitor cells, the primary reservoir for latent cytomegalovirus is unknown. We analyzed human hematopoietic subpopulations infected in vitro with a recombinant virus that expresses a green fluorescent protein marker gene. Although many hematopoietic cell subsets were infected in vitro, CD14+ monocytes and various CD34+ subpopulations were infected with the greatest efficiency. We have developed an in vitro system in which to study HCMV infection and latency in CD34+ cells cultured with irradiated stromal cells. Marker gene expression was substantially reduced by 4 days postinfection, and infectious virus was not made during the culture period. However, viral DNA sequences were maintained in infected CD34+ cells for >20 days in culture, and, importantly, virus replication could be reactivated by coculture with human fibroblasts. Using an HCMV gene array, we examined HCMV gene expression in CD34+ cells. The pattern of viral gene expression was distinct from that observed during productive or nonproductive infections. Some of these expressed viral genes may function in latency and are targets for further analysis. Altered gene expression in hematopoietic progenitors may be indicative of the nature and outcome of HCMV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456880      PMCID: PMC138598          DOI: 10.1073/pnas.252630899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.

Authors:  Emily J Paulson; Joyce D Fingeroth; John L Yates; Samuel H Speck
Journal:  Virology       Date:  2002-07-20       Impact factor: 3.616

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs.

Authors:  E P Browne; B Wing; D Coleman; T Shenk
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.

Authors:  E J Paulson; S H Speck
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells.

Authors:  H Sindre; G E Tjøonnfjord; H Rollag; T Ranneberg-Nilsen; O P Veiby; S Beck; M Degré; K Hestdal
Journal:  Blood       Date:  1996-12-15       Impact factor: 22.113

Review 7.  Human cytomegalovirus persistence and latency in endothelial cells and macrophages.

Authors:  Michael A Jarvis; Jay A Nelson
Journal:  Curr Opin Microbiol       Date:  2002-08       Impact factor: 7.934

8.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.

Authors:  J Taylor-Wiedeman; J G Sissons; L K Borysiewicz; J H Sinclair
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

9.  Human cytomegalovirus: glycoproteins associated with virions and dense bodies.

Authors:  M F Stinski
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

10.  Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.

Authors:  R D Schrier; J A Nelson; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

View more
  153 in total

1.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Authors:  Song Hee Lee; Robert F Kalejta; Julie Kerry; Oliver John Semmes; Christine M O'Connor; Zia Khan; Benjamin A Garcia; Thomas Shenk; Eain Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  Experimental human cytomegalovirus latency in CD14+ monocytes.

Authors:  Danna Hargett; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

4.  Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Authors:  Benjamin A Krishna; Monica S Humby; William E Miller; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

5.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

6.  Dynamics of Human Cytomegalovirus Infection in CD34+ Hematopoietic Cells and Derived Langerhans-Type Dendritic Cells.

Authors:  Roxanne Coronel; Sachiko Takayama; Timothy Juwono; Laura Hertel
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

7.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  A cis element between the TATA Box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication.

Authors:  Hiroki Isomura; Mark F Stinski; Ayumi Kudoh; Sanae Nakayama; Takayuki Murata; Yoshitaka Sato; Satoko Iwahori; Tatsuya Tsurumi
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus.

Authors:  Alex Petrucelli; Michael Rak; Lora Grainger; Felicia Goodrum
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection.

Authors:  Lila A Farrington; Tameka A Smith; Finn Grey; Ann B Hill; Christopher M Snyder
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.